Antivenom Market 2027 by Type, Species, Mode of Action and Geography | The Insight Partners

Antivenom Market Forecast to 2027 - Covid-19 Impact and Global Analysis - By Type (Monovalent Antivenom, Polyvalent Antivenom); Species (Snake, Scorpion, Spider, Others); Mode of Action (Cytotoxic, Neurotoxic, Haemotoxic, Cardiotoxic, Myotoxic) and Geography

Report Code: TIPRE00008534 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Antivenom (or antivenin) is a biological product used to treat venomous bites or stings. Antivenom is developed by extracting venom from the relevant species of animal, which includes snakes, insects, spiders, fish, etc. The use of these antivenom drugs are for the several reactions occurring to victims who develop local, systemic, or laboratory evidence.

MARKET DYNAMICS

The antivenom market is projected to grow in the forecast period owing to the increasing government initiatives to promote the development of high-quality antivenom products, rising number of snake bite victims in emerging nations. Moreover, the growth in research and developments by major players for the advanced antivenom products are also offering opportunities in market growth during the forecast period.

MARKET SCOPE

The "Global Antivenom Market Analysis to 2027" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of antivenom market with detailed market segmentation by type, species, mode of action and geography. The global antivenom market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Antivenom market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global antivenom market is segmented on the basis of type, species, and mode of action. Based on type, the market is segmented into monovalent antivenom and polyvalent antivenom. Based on species, the market is segmented into snake, scorpion, spider, and others. Based on mode of action, the antivenom market is segmented into cytotoxic, neurotoxic, haemotoxic, cardiotoxic, and myotoxic.


REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global antivenom market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The antivenom market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting antivenom market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the antivenom market in these regions.




Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Antivenom market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Antivenom market are anticipated to lucrative growth opportunities in the future with the rising demand for Antivenom market in the global market. Below mentioned is the list of few companies engaged in the Antivenom market.

The report also includes the profiles of key Antivenom market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

- BTG International Inc.
- Pfizer Inc.
- Merck KGaA
- Boehringer Ingelheim
- Seqirus
- Laboratorios Silanes
- Bharat Serums and Vaccines Limited
- HAFFKINE BIO-PHARMACEUTICAL CORPORATION LTD.
- MicroPharm
- Rare Disease Therapeutics, Inc.

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Antivenom Market - By Type
1.3.2 Antivenom Market - By Species
1.3.3 Antivenom Market - By Mode of Action
1.3.4 Antivenom Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ANTIVENOM MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ANTIVENOM MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. ANTIVENOM MARKET - GLOBAL MARKET ANALYSIS
6.1. ANTIVENOM - GLOBAL MARKET OVERVIEW
6.2. ANTIVENOM - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
?
7. ANTIVENOM MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. MONOVALENT ANTIVENOM
7.3.1. Overview
7.3.2. Monovalent Antivenom Market Forecast and Analysis
7.4. POLYVALENT ANTIVENOM
7.4.1. Overview
7.4.2. Polyvalent Antivenom Market Forecast and Analysis
8. ANTIVENOM MARKET - REVENUE AND FORECASTS TO 2027 - SPECIES
8.1. OVERVIEW
8.2. SPECIES MARKET FORECASTS AND ANALYSIS
8.3. SNAKE
8.3.1. Overview
8.3.2. Snake Market Forecast and Analysis
8.4. SCORPION
8.4.1. Overview
8.4.2. Scorpion Market Forecast and Analysis
8.5. SPIDER
8.5.1. Overview
8.5.2. Spider Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis
9. ANTIVENOM MARKET - REVENUE AND FORECASTS TO 2027 - MODE OF ACTION
9.1. OVERVIEW
9.2. MODE OF ACTION MARKET FORECASTS AND ANALYSIS
9.3. CYTOTOXIC
9.3.1. Overview
9.3.2. Cytotoxic Market Forecast and Analysis
9.4. NEUROTOXIC
9.4.1. Overview
9.4.2. Neurotoxic Market Forecast and Analysis
9.5. HAEMOTOXIC
9.5.1. Overview
9.5.2. Haemotoxic Market Forecast and Analysis
9.6. CARDIOTOXIC
9.6.1. Overview
9.6.2. Cardiotoxic Market Forecast and Analysis
9.7. MYOTOXIC
9.7.1. Overview
9.7.2. Myotoxic Market Forecast and Analysis
10. ANTIVENOM MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Antivenom Market Overview
10.1.2 North America Antivenom Market Forecasts and Analysis
10.1.3 North America Antivenom Market Forecasts and Analysis - By Type
10.1.4 North America Antivenom Market Forecasts and Analysis - By Species
10.1.5 North America Antivenom Market Forecasts and Analysis - By Mode of Action
10.1.6 North America Antivenom Market Forecasts and Analysis - By Countries
10.1.6.1 United States Antivenom Market
10.1.6.1.1 United States Antivenom Market by Type
10.1.6.1.2 United States Antivenom Market by Species
10.1.6.1.3 United States Antivenom Market by Mode of Action
10.1.6.2 Canada Antivenom Market
10.1.6.2.1 Canada Antivenom Market by Type
10.1.6.2.2 Canada Antivenom Market by Species
10.1.6.2.3 Canada Antivenom Market by Mode of Action
10.1.6.3 Mexico Antivenom Market
10.1.6.3.1 Mexico Antivenom Market by Type
10.1.6.3.2 Mexico Antivenom Market by Species
10.1.6.3.3 Mexico Antivenom Market by Mode of Action
10.2. EUROPE
10.2.1 Europe Antivenom Market Overview
10.2.2 Europe Antivenom Market Forecasts and Analysis
10.2.3 Europe Antivenom Market Forecasts and Analysis - By Type
10.2.4 Europe Antivenom Market Forecasts and Analysis - By Species
10.2.5 Europe Antivenom Market Forecasts and Analysis - By Mode of Action
10.2.6 Europe Antivenom Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Antivenom Market
10.2.6.1.1 Germany Antivenom Market by Type
10.2.6.1.2 Germany Antivenom Market by Species
10.2.6.1.3 Germany Antivenom Market by Mode of Action
10.2.6.2 France Antivenom Market
10.2.6.2.1 France Antivenom Market by Type
10.2.6.2.2 France Antivenom Market by Species
10.2.6.2.3 France Antivenom Market by Mode of Action
10.2.6.3 Italy Antivenom Market
10.2.6.3.1 Italy Antivenom Market by Type
10.2.6.3.2 Italy Antivenom Market by Species
10.2.6.3.3 Italy Antivenom Market by Mode of Action
10.2.6.4 Spain Antivenom Market
10.2.6.4.1 Spain Antivenom Market by Type
10.2.6.4.2 Spain Antivenom Market by Species
10.2.6.4.3 Spain Antivenom Market by Mode of Action
10.2.6.5 United Kingdom Antivenom Market
10.2.6.5.1 United Kingdom Antivenom Market by Type
10.2.6.5.2 United Kingdom Antivenom Market by Species
10.2.6.5.3 United Kingdom Antivenom Market by Mode of Action
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Antivenom Market Overview
10.3.2 Asia-Pacific Antivenom Market Forecasts and Analysis
10.3.3 Asia-Pacific Antivenom Market Forecasts and Analysis - By Type
10.3.4 Asia-Pacific Antivenom Market Forecasts and Analysis - By Species
10.3.5 Asia-Pacific Antivenom Market Forecasts and Analysis - By Mode of Action
10.3.6 Asia-Pacific Antivenom Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Antivenom Market
10.3.6.1.1 Australia Antivenom Market by Type
10.3.6.1.2 Australia Antivenom Market by Species
10.3.6.1.3 Australia Antivenom Market by Mode of Action
10.3.6.2 China Antivenom Market
10.3.6.2.1 China Antivenom Market by Type
10.3.6.2.2 China Antivenom Market by Species
10.3.6.2.3 China Antivenom Market by Mode of Action
10.3.6.3 India Antivenom Market
10.3.6.3.1 India Antivenom Market by Type
10.3.6.3.2 India Antivenom Market by Species
10.3.6.3.3 India Antivenom Market by Mode of Action
10.3.6.4 Japan Antivenom Market
10.3.6.4.1 Japan Antivenom Market by Type
10.3.6.4.2 Japan Antivenom Market by Species
10.3.6.4.3 Japan Antivenom Market by Mode of Action
10.3.6.5 South Korea Antivenom Market
10.3.6.5.1 South Korea Antivenom Market by Type
10.3.6.5.2 South Korea Antivenom Market by Species
10.3.6.5.3 South Korea Antivenom Market by Mode of Action
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Antivenom Market Overview
10.4.2 Middle East and Africa Antivenom Market Forecasts and Analysis
10.4.3 Middle East and Africa Antivenom Market Forecasts and Analysis - By Type
10.4.4 Middle East and Africa Antivenom Market Forecasts and Analysis - By Species
10.4.5 Middle East and Africa Antivenom Market Forecasts and Analysis - By Mode of Action
10.4.6 Middle East and Africa Antivenom Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Antivenom Market
10.4.6.1.1 South Africa Antivenom Market by Type
10.4.6.1.2 South Africa Antivenom Market by Species
10.4.6.1.3 South Africa Antivenom Market by Mode of Action
10.4.6.2 Saudi Arabia Antivenom Market
10.4.6.2.1 Saudi Arabia Antivenom Market by Type
10.4.6.2.2 Saudi Arabia Antivenom Market by Species
10.4.6.2.3 Saudi Arabia Antivenom Market by Mode of Action
10.4.6.3 U.A.E Antivenom Market
10.4.6.3.1 U.A.E Antivenom Market by Type
10.4.6.3.2 U.A.E Antivenom Market by Species
10.4.6.3.3 U.A.E Antivenom Market by Mode of Action
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Antivenom Market Overview
10.5.2 South and Central America Antivenom Market Forecasts and Analysis
10.5.3 South and Central America Antivenom Market Forecasts and Analysis - By Type
10.5.4 South and Central America Antivenom Market Forecasts and Analysis - By Species
10.5.5 South and Central America Antivenom Market Forecasts and Analysis - By Mode of Action
10.5.6 South and Central America Antivenom Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Antivenom Market
10.5.6.1.1 Brazil Antivenom Market by Type
10.5.6.1.2 Brazil Antivenom Market by Species
10.5.6.1.3 Brazil Antivenom Market by Mode of Action
10.5.6.2 Argentina Antivenom Market
10.5.6.2.1 Argentina Antivenom Market by Type
10.5.6.2.2 Argentina Antivenom Market by Species
10.5.6.2.3 Argentina Antivenom Market by Mode of Action
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. ANTIVENOM MARKET, KEY COMPANY PROFILES
12.1. BTG INTERNATIONAL INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. PFIZER INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. MERCK KGAA
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. BOEHRINGER INGELHEIM
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. SEQIRUS
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. LABORATORIOS SILANES
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. BHARAT SERUMS AND VACCINES LIMITED
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. HAFFKINE BIO-PHARMACEUTICAL CORPORATION LTD.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. MICROPHARM
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. RARE DISEASE THERAPEUTICS, INC.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. BTG International Inc.
2. Pfizer Inc.
3. Merck KGaA
4. Boehringer Ingelheim
5. Seqirus
6. Laboratorios Silanes
7. Bharat Serums and Vaccines Limited
8. HAFFKINE BIO-PHARMACEUTICAL CORPORATION LTD.
9. MicroPharm
10. Rare Disease Therapeutics, Inc.
TIPRE00008534
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking